Literature DB >> 31811311

COPD as an independent risk factor for osteoporosis and fractures.

M G Adas-Okuma1, S S Maeda2, M R Gazzotti3, C M Roco3, C O Pradella3, O A Nascimento3, E F Porto3, J G H Vieira2, J R Jardim3, M Lazaretti-Castro2.   

Abstract

Fractures are common in individuals with COPD and occur at higher bone mass values than expected. COPD appears to be an important risk factor for bone fragility.
INTRODUCTION: Patients with chronic obstructive pulmonary disease (COPD) have an increased risk of osteoporosis and fractures, but screening and prophylactic measures to prevent both disorders are often neglected in this population. This case-control study assessed the prevalence of osteopenia, osteoporosis, and fractures in patients with COPD, and identified potential risk factors for fractures in this population.
METHODS: Overall, 91 patients with COPD (COPD group; COPDG) and 81 age- and sex-matched controls (control group; CG) were assessed with bone mineral density (BMD), thoracic/lumbar spine radiographs, and serum PTH and 25-hydroxyvitamin D (25[OH]D) levels. The occurrence of prior fractures was retrieved from clinical history.
RESULTS: The prevalence of total fractures in the COPDG was 57.1% (odds of fracture 4.7 times greater compared with the CG), and the femoral neck T-score emerged as the best predictor of fractures. Compared with the CG, the COPDG had lower spine and femoral BMD (p ≤ 0.01) and 25(OH)D levels (p = 0.01) and 2.6 times greater odds of osteoporosis. Among men, vertebral fractures were more prevalent in the COPDG versus CG (25.9% vs. 6.5%, respectively, p = 0.01). The odds of fracture increased with femoral neck T-scores ≤ - 2.7 in the CG and ≤ - 0.6 in the COPDG.
CONCLUSION: These results add robust evidence to an increased odds of osteoporosis and fractures in COPD. Fractures in the COPDG occurred at higher BMD values than expected, suggesting that COPD may be an independent marker of fracture risk, reinforcing a need for regular osteoporosis screening with BMD measurement and prophylaxis of fractures in patients with this disorder.

Entities:  

Keywords:  Bone fracture; Bone mineral density; Chronic obstructive pulmonary disease; DXA scan; Osteoporosis

Year:  2019        PMID: 31811311     DOI: 10.1007/s00198-019-05235-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  36 in total

Review 1.  Vitamin D deficiency: What does it mean for chronic obstructive pulmonary disease (COPD)? a compherensive review for pulmonologists.

Authors:  Nurdan Kokturk; Ayse Baha; Yeon-Mok Oh; Jung Young Ju; Paul W Jones
Journal:  Clin Respir J       Date:  2017-01-05       Impact factor: 2.570

Review 2.  Role of HIF-1alpha in skeletal development.

Authors:  Chao Wan; Jin Shao; Shawn R Gilbert; Ryan C Riddle; Fanxin Long; Randall S Johnson; Ernestina Schipani; Thomas L Clemens
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

3.  Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease.

Authors:  Carolina A M Kulak; Victoria C Borba; Vanda Jorgetti; Luciene M Dos Reis; Xiaowei S Liu; Donald B Kimmel; Jaime Kulak; Leda M Rabelo; Hua Zhou; X Edward Guo; John P Bilezikian; Cesar L Boguszewski; David W Dempster
Journal:  J Bone Miner Res       Date:  2010-09       Impact factor: 6.741

4.  Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort.

Authors:  Jessica Bon; Carl R Fuhrman; Joel L Weissfeld; Steven R Duncan; Robert A Branch; Chung-Chou H Chang; Yingze Zhang; Joseph K Leader; David Gur; Susan L Greenspan; Frank C Sciurba
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405

Review 5.  COPD and osteoporosis.

Authors:  Diane M Biskobing
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

Review 6.  Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should).

Authors:  Alvar Agustí
Journal:  Proc Am Thorac Soc       Date:  2007-10-01

Review 7.  Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review.

Authors:  S Nayak; D L Edwards; A A Saleh; S L Greenspan
Journal:  Osteoporos Int       Date:  2013-10-09       Impact factor: 4.507

8.  Hypoxia decreases Runx2/Cbfa1 expression in human osteoblast-like cells.

Authors:  J H Park; B H Park; H K Kim; T S Park; H S Baek
Journal:  Mol Cell Endocrinol       Date:  2002-06-28       Impact factor: 4.102

9.  The association of race, gender, and comorbidity with mortality and function after hip fracture.

Authors:  Joan D Penrod; Ann Litke; William G Hawkes; Jay Magaziner; John T Doucette; Kenneth J Koval; Stacey B Silberzweig; Kenneth A Egol; Albert L Siu
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-08       Impact factor: 6.053

Review 10.  Bone turnover markers: understanding their value in clinical trials and clinical practice.

Authors:  R Civitelli; R Armamento-Villareal; N Napoli
Journal:  Osteoporos Int       Date:  2009-02-04       Impact factor: 4.507

View more
  5 in total

1.  New technology REMS for bone evaluation compared to DXA in adult women for the osteoporosis diagnosis: a real-life experience.

Authors:  Débora Meira Ramos Amorim; Eliane Naomi Sakane; Sergio Setsuo Maeda; Marise Lazaretti Castro
Journal:  Arch Osteoporos       Date:  2021-11-16       Impact factor: 2.617

2.  Association of sarcopenia with osteoporosis in patients with chronic obstructive pulmonary disease.

Authors:  Jamie R Chua; Michael L Tee
Journal:  Osteoporos Sarcopenia       Date:  2020-08-21

3.  Associations between bone mineral density and chronic obstructive pulmonary disease.

Authors:  Xiaodiao Zhang; Keke Ding; Xiaqi Miao; Jianing Wang; Binbin Hu; Jiamin Shen; Xueting Hu; Yage Xu; Beibei Yu; Tingting Tu; Aiju Lin; Xianjing Chen; Yiben Huang
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

4.  Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis.

Authors:  Shunsuke Uno; Takanori Asakura; Kozo Morimoto; Kimio Yoshimura; Yoshifumi Uwamino; Tomoyasu Nishimura; Yoshihiko Hoshino; Naoki Hasegawa
Journal:  BMC Pulm Med       Date:  2020-10-09       Impact factor: 3.317

Review 5.  Towards Personalized Management of Sarcopenia in COPD.

Authors:  Sophie I J van Bakel; Harry R Gosker; Ramon C Langen; Annemie M W J Schols
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.